MedTrace Logo

Stem Cells and Resynchronization Cardiac

NCT00800657 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2011-06-23

No results posted yet for this study

Summary

Same patients with dilated myocardiopathies with large areas of fibrosis has not been as successful after Cardiac Resynchronization Therapy, for Heart Failure patients in functional class III or IV. Therefore the investigators have decided to associate the Stem-Cell implant with Cardiac Resynchronization Therapy in these patients.

Conditions

Interventions

PROCEDURE

Pacing and Stem Cells Implantations.

Implantation of Cardiac Ressyncrhonization combined with the implantation of Stem Cells Hematopoietics.

PROCEDURE

Pacing and Stem Cells Implantation

Pacing and Stem Cells Implantation.

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Instituto de Molestias Cardiovasculares

    lead OTHER

Principal Investigators

  • Oswaldo Tadeu Greco, PhD · IMC - Institute of Hearth Diseases

  • Oswaldo Tadeu Greco, PhD · IMC- Institute of Hearth Diseases

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00800657 on ClinicalTrials.gov